Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on September 14, 2026

Sep. 14, 2026

Rodney Powell is TEXAS #1 Top Local Agent on Medicare Agents Hub for Second Consecutive Year

Indeterminate EIN Presswire

Sep. 14, 2026

Eating Disorder Solutions Launches Free, Clinically Reviewed Self-Assessment Tools

Indeterminate EIN Presswire

Sep. 14, 2026

Discovery Texas Interventional Psychiatry Reports Strong Depression Outcomes From TMS Therapy Program

Indeterminate EIN Presswire

Sep. 14, 2026

ER/Studio 21.1 Expands Data Models Into Semantic Layers for AI and Analytics

Indeterminate EIN Presswire

Sep. 14, 2026

AI M&A in 2026: Major Deals and Companies Driving Industry Growth

Indeterminate EIN Presswire

Sep. 14, 2026

BlueCloudX® Launches New Website, Designed to Simplify the Global Healthcare and Clinical Research Experience

Indeterminate EIN Presswire

Sep. 14, 2026

Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 14, 2026

From Former Patient to Clinical Leader: Oxford Treatment Center Promotes Kate Bell to Outpatient Clinical Manager

Indeterminate GlobeNewswire

Sep. 14, 2026

Ascendis Announces Planned $400 Million Share Repurchase Program

Indeterminate GlobeNewswire

Sep. 14, 2026

Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases

Indeterminate GlobeNewswire

Sep. 14, 2026

Curium™ announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for adults with SSTR-positive GEP-NETs

Indeterminate GlobeNewswire

Sep. 14, 2026

Onspire Health Marketing Clients Earn Five Gold Healthcare Advertising Awards

Indeterminate GlobeNewswire

Sep. 14, 2026

As Lithium Battery Markets Scale, Americase Experts to Address Safety and Compliance Challenges at LithiumSAFE 2026

Indeterminate EIN Presswire

Sep. 14, 2026

DLH Appoints Brooke Pierce President of Health Business Group

Indeterminate GlobeNewswire

Sep. 14, 2026

Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study

Indeterminate GlobeNewswire

Sep. 14, 2026

PetMeds Appoints Andrew Parry as Chief Technology Officer

Indeterminate GlobeNewswire

Sep. 14, 2026

Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer

Indeterminate GlobeNewswire

Sep. 14, 2026

NurExone and NanoPass Technologies Ltd. to Collaborate on Integrated Exosome Delivery Approach for Regenerative Eye and Skin Applications

Indeterminate GlobeNewswire

Sep. 14, 2026

Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial

Indeterminate GlobeNewswire

Sep. 14, 2026

Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings

Indeterminate GlobeNewswire